Intraarticular Steroids, Saline and Occupational Therapy in People With CMC1 Osteoarthritis
A legfontosabb adatok
- Ki végzi
- Diakonhjemmet Hospital
- Hol
- Norvégia6 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Fut, nem toboroz
- Fázis
- 4. fázis
- Résztvevők
- 354 fő, tervezett
- Kezdés
- 2023. nov. 3.
- Várható befejezés
- 2028. nov.
- A vizsgálat típusa
- Beavatkozással járó, 3 csoportAz egyik csoport placebót (hatóanyag nélküli szert) kap, összehasonlításként.
- A vizsgált kezelések
- Injection of triamcinolone acetonide into the CMC-1 joint
- Multimodal Occupational therapy for CMC-1 joint OA
- Placebo
- A regiszteradat frissítve
- 2026. november 2.
Ki vehet részt
- Életkor
- 40 év – 85 év
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 25 feltétel megnézéseKevesebb
Ki vehet részt
- Adult (40-85 years of age) men and women; In target CMC-1 joint:
- OA confirmed by radiographs or ultrasound examination, and
- Inflammation by ultrasound (grey scale synovitis grade 1-3), and
- Pain of at least 3 on a 0-10 Numeric Rating Scale (NRS) at rest or during activities at both pre-screening and screening
- Patient is assessed as eligible for the proposed use of Kenacort-T
Ki nem vehet részt
- More than 3 previous IACS in the target CMC-1 joint
- Use of oral, intramuscular or intravenous steroids in the last 12 weeks
- Previous surgery of the target CMC-1 joint
- Planned hand surgery in the coming 24 weeks
- Systemic inflammatory joint diseases (such as rheumatoid arthritis (RA), psoriatic arthritis or gout) or other conditions that can better explain the hand pain (such as thoracic outlet syndrome, carpal tunnel disease, diabetic cheiropathy, hand injury in previous six months, or palmar tenosynovitis/trigger finger)
- Patients vaccinated or immunized with live virus vaccines in the last 2 weeks
- Infection, skin disease or wounds at joint injection site
- Serious comorbidities, cognitive dysfunction, substance/alcohol abuse or any other medical condition that makes adherence to the study protocol difficult
- Severe or uncontrolled infections
- Any condition that in the view of the investigator would suggest that the patient is unable to comply with the study protocol and procedures
- Known hypersensitivity to Triamcinolone acetonide (Kenacort) or any of the excipients (sodium carboxymethylcellulose, sodium chloride, polysorbate, benzyl alcohol, sodium hydroxide or hydrochloric acid)
- Use of thumb orthosis on most of the days or structured hand exercises in the last 12 weeks
- Intraarticular injections in the target CMC-1 joint in the last 12 weeks
- Do not want to quit using oral or topical NSAIDs on the hands (such as ibuprofen, diclofenac, etoricoxib, naproxen) in the next 12 weeks
- Diagnosis of fibromyalgia
- Diagnosis of psoriasis
- Included in another clinical study
- Use of digitalis glycosides
- Not being able to talk or understand Norwegian
- Known pregnancy or planned pregnancy in the next 6 months
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
A placebo-controlled randomized controlled trial exploring the effect of intraarticular steroids, saline or an occupational therapy intervention in inflammatory carpometacarpal-1 osteoarthritis
A vizsgálat 3 csoportja
- Intraarticular corticosteroid injection (IACS)A vizsgált kezelés
A single ultrasound-guided intraarticular injection of 0.50 ml of 40 mg/ml triamcinolone acetonide at baseline. A smaller dosage can be considered if there is increased resistance during injection. The same injection procedure will be repeated after 12 weeks if there is pain (NRS≥3) and inflammation (grey scale synovitis grade 1-3) present in the CMC-1 joint.
Kezelés: Injection of triamcinolone acetonide into the CMC-1 joint
- Saline injectionPlacebo, összehasonlításként
A single ultrasound-guided intraarticular injection of 0.50 ml of sodium chloride 9 mg/ml at baseline. A smaller dosage can be considered if there is increased resistance during injection. The same injection procedure will be repeated after 12 weeks if there is pain (NRS≥3) and inflammation (grey scale synovitis grade 1-3) present in the CMC-1 joint.
Kezelés: Placebo
- Occupational Therapy interventionA vizsgált kezelés
Patient education, instructions about hand exercises and training in the Happy Hands app. Administration of day and night orthosis. The Happy Hands app involves a 12 week intervention.
Kezelés: Multimodal Occupational therapy for CMC-1 joint OA
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Painful Inflammatory Carpometacarpal-1 Osteoarthritis Treated With Intraarticular Steroids, Saline or an Occupational Therapy Intervention: the PICASSO Trial.
- Publikációk
- A regiszteradat frissítve
- 2026. november 2.